QXL Quantum X Labs Inc. - Common Stock
$4.30
Price · Aug 19, 2026
Fundamentals as of Aug 13, 2026
QXL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.30
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$3 – $8
QXL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
QXL
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
QXL
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
QXL
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
QXL
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
QXL
Peer Median
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| QXL | — | — | — | — | — | — |
| PERI | — | — | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Revenue | $293.0K | $370.0K | |
| R&D Expense | $185.0K | $20.0K | |
| SG&A Expense | $1M | $558.0K | |
| Operating Income | $-1M | $-1M | |
| Interest Income | · | $25.0K | |
| Pretax Income | $2M | $-9M | |
| Income Tax | $-94.0K | $-67.0K | |
| Net Income | $2M | $-12M | |
| EPS (Basic) | $0.17 | $-1.61 | |
| EPS (Diluted) | $0.12 | $-1.61 | |
| Shares (Basic) | 14,292,085 | 7,235,599 | |
| Shares (Diluted) | 20,074,625 | 7,235,599 | |
| EBITDA | $-1M | · |
Balance Sheet 19
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Cash & Equivalents | $2M | · | |
| Receivables | $281.0K | · | |
| Other Current Assets | $394.0K | · | |
| Current Assets | $3M | · | |
| PP&E (Net) | $205.0K | · | |
| Goodwill | $21M | · | |
| Intangibles | $2M | · | |
| Total Assets | $31M | · | |
| Accounts Payable | $1M | · | |
| Short-term Debt | $262.0K | · | |
| Current Liabilities | $4M | · | |
| Deferred Tax | $416.0K | · | |
| Long-term Debt | $976.0K | · | |
| Total Debt | $1M | · | |
| Common Stock | $5.0K | · | |
| Retained Earnings | $-44M | · | |
| Stockholders' Equity | $26M | · | |
| Liabilities + Equity | $31M | · | |
| Shares Outstanding | 18,829,198 | · |
Cash Flow 9
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| D&A | $228.0K | $235.0K | |
| Stock-based Comp | · | $75.0K | |
| Amort. of Intangibles | $203.0K | · | |
| Operating Cash Flow | $-1M | $-480.0K | |
| CapEx | $186.0K | · | |
| Net Debt Issued | $-195.0K | · | |
| Net Change in Cash | $645.0K | $2M | |
| Taxes Paid | $10.0K | $4.0K | |
| Free Cash Flow | $-1M | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Operating Margin | -476.1% | · | |
| Net Margin | 848.1% | · | |
| Pretax Margin | 792.8% | · | |
| EBITDA Margin | -476.1% | · | |
| ROA | 9.7% | · | |
| ROE | 16.4% | · | |
| ROIC | -5.4% | · |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Current Ratio | 0.9 | · | |
| Quick Ratio | 0.7 | · | |
| Debt / Equity | 0.0 | · | |
| LT Debt / Equity | 0.0 | · |
Efficiency 2
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 0.4 | · |
Valuation (TTM) 11
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Net Income TTM | $-13M | · | |
| Market Cap | $107M | · | |
| Enterprise Value | $106M | · | |
| P/E | -5.1 | · | |
| P/B | 4.2 | · | |
| P / Tangible Book | 38.8 | · | |
| P / Cash Flow | -101.1 | · | |
| P / FCF | -86.0 | · | |
| EV / EBITDA | -76.1 | · | |
| EV / FCF | -85.0 | · | |
| Earnings Yield | -19.7% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Company insiders 2 insiders · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Estery Giloz-Ran | — | Feb. 24, 2016 A | 690,323 | 0 | 0 | $0 |
| Ivo Heiden | — | Aug. 18, 2008 A | 766,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Eliyahu Yoresh (1), Liron Carmel (1) | Oct. 3, 2022 | — | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person | Aug. 13, 2019 | — | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.